Kyrgyzstan is one of the 30 global high-burden countries for multidrug-resistant tuberculosis (MDR-TB), and the country experienced a significant decline in the number of people diagnosed and treated for TB and MDR-TB during the COVID-19 pandemic. National TB Program (NTP) data show a 32 percent decrease in cases detected in 2020 compared to 2019. A baseline situational analysis conducted in 2019 by the USAID Cure Tuberculosis project, led by JSI, in 12 general hospitals in Chui, Naryn, and Osh Oblasts (regions), and Bishkek city showed that there was no systematic screening for TB among patients seeking care in general hospital settings. The project piloted a health provider-initiated TB active case finding (ACF) model based on the FAST (Find TB cases Actively, Separate safely, and Treat effectively) approach to screen patients with respiratory symptoms or diseases admitted to general hospitals.
We strive to build lasting relationships to produce better health outcomes for all.
